pfizer glp-1 drug weight loss available for pre-order in China China Opens Its Weight-Loss Drug

Your body depends on glucose for energy

Novo-Nordisk A/S, Eli Lilly And Company, Sanofi, AstraZeneca, Pfizer Inc., Amgen, Inc., and Innovent Biologics, Inc

GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking behaviors through central reward and dopamine-related pathways

This brief discusses the current landscape of Medicaid GLP-1 coverage and examines recent trends in Medicaid prescriptions and gross spending on GLP-1s.

Explore a complete 2026 guide to GLP-1 receptor agonists, including an updated drug list, indications, dosing basics, side effects, and safety considerations to discuss with your healthcare provider.